欧洲药典适用性证书数据库
(Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM)
专论编号 物质名称 证书持有人 持有人ORG-ID和LOC-ID 证书编号 发布日期 证书状态 到期续期 证书结束日期 证书类型 上一程序的结束日期 历史数据
程序类型|结论|日期
2598 Levofloxacin hemihydrate MACLEODS PHARMACEUTICALS LIMITED Mumbai IN 100021441;100077265 CEP 2021-448 - Rev 02 2025/08/21 Valid 02/07/2029 Chemical 2025/08/21 Minor revision|CEP granted|21/08/2025;
Major revision|CEP granted|10/02/2025;
New application|CEP granted|02/07/2024
2269 Sevoflurane, Recovered EXDRA GMBH Grafing bei München DE 100044971;100074267 CEP 2022-208 - Rev 00 2025/08/21 Valid 21/08/2030 Chemical 2025/08/21 New application|CEP granted|21/08/2025
2777 Pregabalin SYMED LABS LIMITED Hyderabad IN 100018727;100053490 CEP 2023-386 - Rev 00 2025/08/21 Valid 21/08/2030 Chemical 2025/08/21 New application|CEP granted|21/08/2025
391 Furosemide HEM-DEEP ORGANICS PRIVATE LIMITED Ankleshwar IN 100048515;100080399 CEP 2023-331 - Rev 00 2025/08/21 Valid 21/08/2030 Chemical 2025/08/21 New application|CEP granted|21/08/2025
2777 Pregabalin, Process VI ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou CN 100011833;100018698 CEP 2025-282 - Rev 00 2025/08/21 Valid 21/08/2030 Chemical 2025/08/21 New application|CEP granted|21/08/2025
575 Cholecalciferol concentrate (oily form), 1 000 000 IU/g, in refined maize oil DSM-FIRMENICH SWITZERLAND AG Kaiseraugst CH 100053293;100094111 CEP 2023-403 - Rev 02 2025/08/21 Valid 02/09/2029 Chemical and TSE 2025/08/21 Minor revision|CEP granted|21/08/2025;
Notification|CEP granted|17/07/2025;
New application|CEP granted|02/09/2024
2778 Sitagliptin phosphate monohydrate, Enzymatic method RUYUAN HEC PHARM CO., LTD. Shaoguan CN 100023129;100031882 CEP 2024-352 - Rev 01 2025/08/21 Valid 03/10/2029 Chemical 2025/08/21 Minor revision|CEP granted|21/08/2025;
New application|CEP granted|03/10/2024
429 Progesterone, Process 2, milled SHAANXI HANJIANG PHARMACEUTICAL GROUP CO., LTD. Hanzhong CN 100012369;100079669 CEP 2024-553 - Rev 00 2025/08/21 Valid 21/08/2030 Chemical 2025/08/21 New application|CEP granted|21/08/2025
2779 Solifenacin succinate OPTIMUS DRUGS PRIVATE LIMITED Hyderabad IN 100020646;100092226 CEP 2019-032 - Rev 03 2025/08/20 Valid Chemical 2025/08/20 Administrative procedure|CEP granted|20/08/2025;
Renewal|CEP granted|31/07/2025;
Major revision|Rejected|27/06/2024;
Minor revision|CEP granted|11/04/2022
1573 Sumatriptan succinate SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN 100008538;100018201 CEP 2009-139 - Rev 02 2025/08/20 Valid Chemical 2025/08/20 Minor revision|CEP granted|20/08/2025
2594 Duloxetine hydrochloride HETERO DRUGS LIMITED Hyderabad IN 100008415;100014434 CEP 2012-305 - Rev 03 2025/08/20 Valid Chemical 2025/08/20 Notification|CEP granted|20/08/2025;
Minor revision|Accepted - CEP remains valid|26/01/2024;
Minor revision|CEP granted|12/01/2023;
Minor revision|Accepted - CEP remains valid|02/08/2021;
Minor revision|CEP granted|22/04/2021
2631 Rosuvastatin calcium NOSCH LABS PRIVATE LIMITED Hyderabad IN 100020550;100029297 CEP 2018-227 - Rev 01 2025/08/20 Valid Chemical 2025/08/20 Renewal|CEP granted|20/08/2025
60 Trimethoprim, Powder, micronised ANDHRA ORGANICS LIMITED Srikakulam IN 100023796;100032964 CEP 2020-157 - Rev 02 2025/08/20 Valid 21/07/2027 Chemical 2025/08/20 Minor revision|CEP granted|20/08/2025;
Monograph revision|CEP granted|04/01/2024;
New application|CEP granted|21/07/2022
2154 Telmisartan, Process-II MICRO LABS LIMITED Bengaluru IN 100017819;100077269 CEP 2020-388 - Rev 02 2025/08/20 Valid 15/03/2026 Chemical 2025/08/20 Minor revision|CEP granted|20/08/2025;
Minor revision|CEP granted|07/10/2021;
New application|CEP granted|15/03/2021
1281 Aceclofenac, Standard, fine, micronised RANKE QUIMICA, S.A. Sant Andreu de la Barca ES 100011757;100054672 CEP 2023-341 - Rev 00 2025/08/20 Valid 20/08/2030 Chemical 2025/08/20 New application|CEP granted|20/08/2025
57 Tetracaine hydrochloride SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou City CN 100048410;100080174 CEP 2024-442 - Rev 00 2025/08/20 Valid 20/08/2030 Chemical 2025/08/20 New application|CEP granted|20/08/2025
1385 Acitretin, Process 2 CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO., LTD. Chongqing CN 100024073;100088372 CEP 2021-012 - Rev 01 2025/08/20 Valid 30/11/2027 Chemical 2025/08/20 Minor revision|CEP granted|20/08/2025;
New application|CEP granted|30/11/2022
2932 Rivaroxaban, Process II (Micronised) ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou CN 100011833;100018698 CEP 2024-014 - Rev 01 2025/08/20 Valid 24/07/2029 Chemical 2025/08/20 Minor revision|CEP granted|20/08/2025;
New application|CEP granted|24/07/2024
429 Progesterone, Process III ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou CN 100022759;100031459 CEP 2025-150 - Rev 00 2025/08/20 Valid 20/08/2030 Chemical 2025/08/20 New application|CEP granted|20/08/2025
967 Acetylcysteine ZACH SYSTEM Avrillé FR 100012282;100021396 CEP 2016-311 - Rev 01 2025/08/19 Valid Chemical 2025/10/24 Minor revision|Accepted - CEP remains valid|24/10/2025;
Minor revision|CEP granted|19/08/2025;
Renewal|CEP granted|07/02/2022;
Monograph revision|Accepted - CEP remains valid|08/01/2021;
Minor revision|CEP granted|15/10/2020

数据库说明:

当前数据更新日期:2025年12月21日。
©2006-2025 DrugFuture->Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM